Exp Neurol, Jul 2014

Response to the report, "A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury" by Sharp et al


Abrams MB, Nilsson I, Kjell J, Lewandowski S, Codeluppi S, Eriksson U, Olson L

 

 

Comment on

A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury. [Exp Neurol. 2014]

 

Read the full text